Ambercrest Apiaries — Financial Plan & Projections
This section presents the full five-year financial plan: key assumptions, the funding structure and use of funds, and the three primary statements — projected profit & loss, balance sheet and cash flow — together with the supporting debt, working-capital and coverage analysis.…
Section 14 · Business Plan
Financial Plan & Projections
This section presents the full five-year financial plan: key assumptions, the funding structure and use of funds, and the three primary statements — projected profit & loss, balance sheet and cash flow — together with the supporting debt, working-capital and coverage analysis.…
At a 35% Year-5 EBITDA margin, building from an early-stage loss to ZAR 6.2 million net profit after tax by Year 5.
This section presents the full five-year financial plan: key assumptions, the funding structure and use of funds, and the three primary statements — projected profit & loss, balance sheet and cash flow — together with the supporting debt, working-capital and coverage analysis. The sponsor’s headline revenue and EBITDA-margin guidance is preserved; everything below EBITDA is independently re-derived on a conservative, bankable basis.
14.1 Key modelling assumptions
| Assumption | Basis |
|---|---|
| Currency | ZAR (USD at R18.3/USD for reference) |
| Corporate tax rate | 27% (with assessed-loss carry-forward) |
| Senior debt rate | 12.5% (prime 10.5% + 2.0% margin) |
| Revolver rate | 13.5% (prime + 3.0%) |
| Debt tenor / grace | 7 years / 12-month principal grace |
| Debtor / inventory / creditor days | 45 / 55 / 30 |
| Depreciation | Straight-line: buildings 20y, hives 7y, plant 10y, packaging 8y, brand 5y |
| Exit assumption | 5.0x EV/EBITDA trade sale at end Year 5 |
| Revenue CAGR (Y1–Y5) | ~59% (sponsor guidance, preserved) |
| EBITDA margin path | 10% → 35% (sponsor guidance, preserved) |
Table 25. Principal financial assumptions.
| Honest-analyst note — the assumptions that matter most Two sponsor assumptions drive the outcome and are flagged as aggressive: a ~59% revenue CAGR and a 25-percentage-point EBITDA-margin expansion over five years. Both are preserved as the base case but stress-tested in Section 16. Interest rates reflect the SARB prime rate of 10.5% prevailing in mid-2026; a rising-rate environment would raise debt service and is captured in the downside scenario. |
14.2 Funding structure and use of funds
The ZAR 18.0 million raise is split evenly between equity and senior debt, supported by a committed revolving working-capital facility and a funded debt-service reserve. This is a deliberately conservative structure for a biological-asset ramp.
| Use of funds (ZAR m) | Amount | Share |
|---|---|---|
| Land | 1.50 | 8% |
| Buildings & facilities | 2.50 | 14% |
| Hives & colonies (2,000) | 5.00 | 28% |
| Extraction & processing plant | 3.00 | 17% |
| Packaging line | 1.20 | 7% |
| Branding & intangibles | 0.80 | 4% |
| DSRA (restricted) | 1.00 | 6% |
| Initial working capital / cash | 3.00 | 17% |
| Total | 18.00 | 100% |
Table 26. Use of the ZAR 18.0 million in funds.
Figure 8. Allocation of the ZAR 18.0 million raise across capital and working-capital uses.
Figure 9. Funding structure: equity and senior debt (50:50).
14.3 Projected profit & loss
Revenue scales from ZAR 5.0m to ZAR 32.0m as the hive base and channel mix mature. The business records losses in Years 1–2 — driven by full depreciation and cash interest against a low early EBITDA — before turning profitable from Year 3, with net margin reaching roughly 19% by Year 5. Assessed losses from the ramp shelter early taxable profits.
| Income statement (ZAR m) | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Revenue | 5.0 | 10.0 | 18.0 | 25.0 | 32.0 |
| Operating costs | (4.5) | (8.0) | (13.0) | (16.8) | (20.8) |
| EBITDA | 0.5 | 2.0 | 5.0 | 8.3 | 11.2 |
| EBITDA margin | 10% | 20% | 28% | 33% | 35% |
| Depreciation & amortisation | (1.5) | (1.6) | (1.7) | (1.9) | (2.1) |
| EBIT | (1.0) | 0.4 | 3.3 | 6.3 | 9.1 |
| Interest (term + revolver) | (1.1) | (1.1) | (1.2) | (1.0) | (0.6) |
| Profit before tax | (2.1) | (0.7) | 2.1 | 5.4 | 8.5 |
| Taxation | 0.0 | 0.0 | 0.0 | (1.3) | (2.3) |
| Net profit after tax | (2.1) | (0.7) | 2.1 | 4.1 | 6.2 |
| Net margin | -42% | -7% | 12% | 16% | 19% |
Table 27. Projected income statement, Years 1–5.
Figure 10. Year-5 profit & loss cascade from revenue to net profit (ZAR million).
14.4 Projected balance sheet
The opening balance sheet is capitalised by the ZAR 18.0 million raise. Net property, plant & equipment declines gently as depreciation outpaces modest expansion capex, while retained earnings rebuild equity after the early losses. The balance sheet ties to zero in every year — enforced programmatically — and net debt deleverages from ZAR 7.8m to near-zero by Year 5.
| Balance sheet (ZAR m) | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Assets | |||||
| Net property, plant & equipment | 12.8 | 12.3 | 11.6 | 10.9 | 10.0 |
| Debt-service reserve (restricted) | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| Cash & equivalents | 1.2 | 0.3 | 0.3 | 0.8 | 2.8 |
| Accounts receivable | 0.6 | 1.2 | 2.2 | 3.1 | 3.9 |
| Inventory | 0.7 | 1.2 | 2.0 | 2.5 | 3.1 |
| Total assets | 16.3 | 15.9 | 17.1 | 18.3 | 20.9 |
| Equity & liabilities | |||||
| Share capital | 9.0 | 9.0 | 9.0 | 9.0 | 9.0 |
| Retained earnings | (2.1) | (2.8) | (0.7) | 3.4 | 7.2 |
| Total equity | 6.9 | 6.2 | 8.3 | 12.4 | 16.2 |
| Senior debt (non-current) | 7.5 | 6.0 | 4.5 | 3.0 | 1.5 |
| Senior debt (current) | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
| Revolving facility | 0.0 | 1.6 | 1.6 | 0.0 | 0.0 |
| Accounts payable | 0.4 | 0.7 | 1.1 | 1.4 | 1.7 |
| Total equity & liabilities | 16.3 | 15.9 | 17.1 | 18.3 | 20.9 |
Table 28. Projected balance sheet, Years 1–5 (ties to zero each year).
Figure 11. Balance-sheet composition: assets versus liabilities and equity (ZAR million).
14.5 Projected cash flow
Operating cash flow turns positive from Year 2 and grows strongly thereafter. Investing outflows are modest — reflecting self-funded, split-based hive expansion — while financing flows capture principal amortisation (from Year 2), revolver movements and dividends (from Year 4). The closing cash position, supported by the revolver in the ramp, never falls below the minimum operating buffer.
| Cash flow (ZAR m) | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Operating cash flow | (1.5) | 0.0 | 2.6 | 4.9 | 7.2 |
| Investing cash flow | (0.3) | (1.0) | (1.1) | (1.2) | (1.2) |
| Financing cash flow | 0.0 | 0.1 | (1.5) | (3.1) | (4.0) |
| Net change in cash | (1.8) | (0.9) | 0.0 | 0.5 | 2.0 |
| Closing cash | 1.2 | 0.3 | 0.3 | 0.8 | 2.8 |
| of which: dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | (2.5) |
| revolver outstanding (year-end) | 0.0 | 1.6 | 1.6 | 0.0 | 0.0 |
Table 29. Projected cash flow statement, Years 1–5.
Figure 12. Cash flow by activity and closing cash balance (ZAR million).
14.6 Debt schedule and working capital
| Senior debt & revolver (ZAR m) | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Term loan — opening | 9.0 | 9.0 | 7.5 | 6.0 | 4.5 |
| Term interest | 1.1 | 1.1 | 0.9 | 0.8 | 0.6 |
| Principal repaid | 0.0 | 1.5 | 1.5 | 1.5 | 1.5 |
| Term loan — closing | 9.0 | 7.5 | 6.0 | 4.5 | 3.0 |
| Revolver drawn (year-end) | 0.0 | 1.6 | 1.6 | 0.0 | 0.0 |
Table 30. Senior debt amortisation and revolver utilisation.
Figure 13. Debt outstanding and net-debt-to-EBITDA deleveraging.
Working capital is sized on 45 debtor days, 55 inventory days and 30 creditor days. Net working capital grows with revenue and is the primary call on the revolving facility during the ramp.
| Working capital (ZAR m) | Y1 | Y2 | Y3 | Y4 | Y5 |
|---|---|---|---|---|---|
| Accounts receivable | 0.6 | 1.2 | 2.2 | 3.1 | 3.9 |
| Inventory | 0.7 | 1.2 | 2.0 | 2.5 | 3.1 |
| Accounts payable | (0.4) | (0.7) | (1.1) | (1.4) | (1.7) |
| Net working capital | 0.9 | 1.8 | 3.1 | 4.2 | 5.4 |
Table 31. Net working-capital build.
14.7 Revenue driver assumptions
The headline revenue path is underpinned by the explicit pricing and volume drivers below, held at conservative, inflation-consistent levels. Honey prices escalate roughly 5% per year; pollination fees track the WCBA/SABIO guideline; per-hive yields sit at the low end of the industry range to reflect the pollination trade-off.
| Driver | Year 1 | Year 5 | Basis / source |
|---|---|---|---|
| Retail honey price (R/kg) | ~200 | ~243 | Premium retail, ~5%/yr escalation |
| Bulk honey price (R/kg) | ~95 | ~115 | Manufacturer offtake pricing |
| Export honey price (R/kg) | ~165 | ~200 | FOB premium, hard-currency linked |
| Honey yield (kg / productive hive) | 20 | 26 | Conservative vs 20–30 kg industry range |
| Pollination fee (R / placement) | 1,450 | 1,760 | WCBA/SABIO guideline, escalated |
| Pollination placements | ~1,100 | ~2,000 | Western Cape orchard contracts |
Table 32. Principal revenue drivers (consistent with the financial model).
This document contains proprietary and confidential information. Distribution without written consent is prohibited.